These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 28302581

  • 1. Targeting ETS1 with RNAi-based supramolecular nanoassemblies for multidrug-resistant breast cancer therapy.
    Wu M, Liu X, Jin W, Li Y, Li Y, Hu Q, Chu PK, Tang G, Ping Y.
    J Control Release; 2017 May 10; 253():110-121. PubMed ID: 28302581
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Olmutinib Reverses Doxorubicin Resistance in ETS1-Overexpressing Leukemia Cells.
    Zhong J, Zhang J, Yu X, Zhang X, Dian L.
    Med Sci Monit; 2020 Aug 24; 26():e924922. PubMed ID: 32830792
    [Abstract] [Full Text] [Related]

  • 4. Hyperbranched-hyperbranched polymeric nanoassembly to mediate controllable co-delivery of siRNA and drug for synergistic tumor therapy.
    Jia HZ, Zhang W, Zhu JY, Yang B, Chen S, Chen G, Zhao YF, Feng J, Zhang XZ.
    J Control Release; 2015 Oct 28; 216():9-17. PubMed ID: 26272764
    [Abstract] [Full Text] [Related]

  • 5. Drug resistant breast cancer cells overexpress ETS1 gene.
    Kars MD, Işeri OD, Gündüz U.
    Biomed Pharmacother; 2010 Sep 28; 64(7):458-62. PubMed ID: 20392592
    [Abstract] [Full Text] [Related]

  • 6. An AS1411 aptamer-conjugated liposomal system containing a bubble-generating agent for tumor-specific chemotherapy that overcomes multidrug resistance.
    Liao ZX, Chuang EY, Lin CC, Ho YC, Lin KJ, Cheng PY, Chen KJ, Wei HJ, Sung HW.
    J Control Release; 2015 Jun 28; 208():42-51. PubMed ID: 25637705
    [Abstract] [Full Text] [Related]

  • 7. Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia.
    To KK, Poon DC, Wei Y, Wang F, Lin G, Fu LW.
    Biochem Pharmacol; 2015 Sep 01; 97(1):27-37. PubMed ID: 26206183
    [Abstract] [Full Text] [Related]

  • 8. Enhanced therapeutic effect of Adriamycin on multidrug resistant breast cancer by the ABCG2-siRNA loaded polymeric nanoparticles assisted with ultrasound.
    Bai M, Shen M, Teng Y, Sun Y, Li F, Zhang X, Xu Y, Duan Y, Du L.
    Oncotarget; 2015 Dec 22; 6(41):43779-90. PubMed ID: 26575421
    [Abstract] [Full Text] [Related]

  • 9. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.
    Bao Y, Yin M, Hu X, Zhuang X, Sun Y, Guo Y, Tan S, Zhang Z.
    J Control Release; 2016 Aug 10; 235():182-194. PubMed ID: 27264552
    [Abstract] [Full Text] [Related]

  • 10. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y, Zhang Y, Zhang W, Sun C, Wu J, Tang J.
    Colloids Surf B Biointerfaces; 2016 Feb 01; 138():60-9. PubMed ID: 26655793
    [Abstract] [Full Text] [Related]

  • 11. Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrier.
    Li JM, Zhang W, Su H, Wang YY, Tan CP, Ji LN, Mao ZW.
    Int J Nanomedicine; 2015 Feb 01; 10():3147-62. PubMed ID: 25960653
    [Abstract] [Full Text] [Related]

  • 12. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH, Shin YJ, Won AJ, Lee BM, Choi WS, Jung JH, Chung HY, Kim HS.
    Biochim Biophys Acta; 2014 Jan 01; 1840(1):615-25. PubMed ID: 24161697
    [Abstract] [Full Text] [Related]

  • 13. Protein arginine methyltransferase 1 may be involved in pregnane x receptor-activated overexpression of multidrug resistance 1 gene during acquired multidrug resistant.
    Li T, Kong AN, Ma Z, Liu H, Liu P, Xiao Y, Jiang X, Wang L.
    Oncotarget; 2016 Apr 12; 7(15):20236-48. PubMed ID: 26934120
    [Abstract] [Full Text] [Related]

  • 14. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J, Fang X, Hao J, Sha X.
    Biomaterials; 2015 Mar 12; 45():99-114. PubMed ID: 25662500
    [Abstract] [Full Text] [Related]

  • 15. Charge-reversal-functionalized PLGA nanobubbles as theranostic agents for ultrasonic-imaging-guided combination therapy.
    Yang H, Shen X, Yan J, Xie X, Chen Z, Li T, Li S, Qin X, Wu C, Liu Y.
    Biomater Sci; 2018 Aug 21; 6(9):2426-2439. PubMed ID: 30040100
    [Abstract] [Full Text] [Related]

  • 16. Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function.
    Feng SL, Yuan ZW, Yao XJ, Ma WZ, Liu L, Liu ZQ, Xie Y.
    Pharmacol Res; 2016 Aug 21; 110():193-204. PubMed ID: 27058921
    [Abstract] [Full Text] [Related]

  • 17. Sequential therapy with redox-responsive glucolipid nanocarrier separately delivering siRNA and doxorubicin to overcome multidrug resistance.
    Meng T, Lu B, Shao S, Yuan M, Liu X, Yuan H, Huang X, Hu F.
    Int J Pharm; 2017 Dec 20; 534(1-2):368-377. PubMed ID: 29051118
    [Abstract] [Full Text] [Related]

  • 18. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C, Guan X, Xue H, Wang P, Wang M, Gai X.
    Pathol Res Pract; 2017 Jul 20; 213(7):848-853. PubMed ID: 28554760
    [Abstract] [Full Text] [Related]

  • 19. Reversing Multidrug Resistance by Multiplexed Gene Silencing for Enhanced Breast Cancer Chemotherapy.
    Li Y, Gao X, Yu Z, Liu B, Pan W, Li N, Tang B.
    ACS Appl Mater Interfaces; 2018 May 09; 10(18):15461-15466. PubMed ID: 29663807
    [Abstract] [Full Text] [Related]

  • 20. Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi).
    Zhang X, Li J, Qiu Z, Gao P, Wu X, Zhou G.
    Cancer Biol Ther; 2009 Jun 09; 8(12):1117-21. PubMed ID: 19502811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.